We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
(+5.8%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
3.2
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.4M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$52M |
| 3 |
Apple
AAPL
|
+$6.85M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.48M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$52.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$44M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.53M |
| 4 |
NVIDIA
NVDA
|
+$4.49M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.08% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 6.53% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
Clearwater Paper
CLW
$308M
| $339 | ﹤0.01% |
7
| – | – |
2022 Q2
8 quarters
|
|
3127
Immunome
IMNM
$2.04B
| $339 | ﹤0.01% |
+28
| New | +$438 |
2024 Q2
0 quarters
|
|
3128
Thryv Holdings
THRY
$53.3M
| $339 | ﹤0.01% |
19
| – | – |
2023 Q4
2 quarters
|
|
3129
NCR Atleos
NATL
$3.42B
| $324 | ﹤0.01% |
12
-2
| -14% | -$49 |
2023 Q4
2 quarters
|
|
3130
Beyond Air
XAIR
$2.13M
| $322 | ﹤0.01% |
+2
| New | +$995 |
2024 Q2
0 quarters
|
|
3131
Supernus Pharmaceuticals
SUPN
$2.32B
| $321 | ﹤0.01% |
12
| – | – |
2022 Q3
7 quarters
|
|
3132
Avita Medical
RCEL
$411M
| $317 | ﹤0.01% |
40
| – | – |
2021 Q1
13 quarters
|
|
3133
DELISTED
ODP
ODP
| $314 | ﹤0.01% |
8
-29
| -78% | -$1.29K |
2022 Q2
8 quarters
|
|
3134
Oil States International
OIS
$481M
| $311 | ﹤0.01% |
70
-616
| -90% | -$2.96K |
2019 Q2
20 quarters
|
|
3135
Ericsson
ERIC
$34.4B
| $302 | ﹤0.01% |
49
+35
| +250% | +$196 |
2023 Q3
3 quarters
|
|
3136
DELISTED
Origin Materials
ORGN
| $301 | ﹤0.01% |
11
| – | – |
2021 Q2
12 quarters
|
|
3137
Banco Bradesco
BBDO
$40.6B
| $300 | ﹤0.01% |
145
-191
| -57% | -$443 |
2022 Q4
6 quarters
|
|
3138
Under Armour Class C
UA
$2.05B
| $300 | ﹤0.01% |
46
-4
| -8% | -$26 |
2016 Q4
30 quarters
|
|
3139
Donnelley Financial Solutions
DFIN
$1.24B
| $298 | ﹤0.01% |
5
| – | – |
2022 Q1
9 quarters
|
|
3140
Invesco India ETF
IMVP
$94.8M
| $292 | ﹤0.01% |
10
| – | – |
2022 Q1
9 quarters
|
|
3141
Cushman & Wakefield Ltd
CWK
$2.71B
| $291 | ﹤0.01% |
28
| – | – |
2023 Q4
2 quarters
|
|
3142
GoodRx Holdings
GDRX
$1.19B
| $289 | ﹤0.01% |
37
| – | – |
2023 Q4
2 quarters
|
|
3143
Hovnanian Enterprises
HOV
$610M
| $284 | ﹤0.01% |
2
| – | – |
2023 Q3
3 quarters
|
|
3144
DELISTED
Olo Inc
OLO
| $283 | ﹤0.01% |
+64
| New | +$303 |
2024 Q2
0 quarters
|
|
3145
RPC Inc
RES
$1.31B
| $281 | ﹤0.01% |
+45
| New | +$315 |
2024 Q2
0 quarters
|
|
3146
Janus International
JBI
$577M
| $278 | ﹤0.01% |
+22
| New | +$307 |
2024 Q2
0 quarters
|
|
3147
Lightspeed Commerce
LSPD
$1.42B
| $274 | ﹤0.01% |
20
| – | – |
2023 Q1
5 quarters
|
|
3148
Centerspace
CSR
$945M
| $271 | ﹤0.01% |
4
| – | – |
2023 Q2
4 quarters
|
|
3149
NanoViricides
NNVC
$35.2M
| $270 | ﹤0.01% |
+157
| New | +$280 |
2024 Q2
0 quarters
|
|
3150
DELISTED
Patterson Companies, Inc.
PDCO
| $270 | ﹤0.01% |
11
-181
| -94% | -$4.53K |
2019 Q4
18 quarters
|
|
Similar funds
Parallel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
- Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
- Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
- Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
- Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.